Page last updated: 2024-10-24

cetylpyridinium and Experimental Lung Inflammation

cetylpyridinium has been researched along with Experimental Lung Inflammation in 2 studies

Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.

Experimental Lung Inflammation: Inflammation of any part, segment or lobe, of the lung parenchyma.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kim, H1
Yoo, J1
Lim, YM1
Kim, EJ1
Yoon, BI1
Kim, P1
Yu, SD1
Eom, IC1
Shim, I1
Larsen, ST1
Verder, H1
Nielsen, GD1

Other Studies

2 other studies available for cetylpyridinium and Experimental Lung Inflammation

ArticleYear
Comprehensive pulmonary toxicity assessment of cetylpyridinium chloride using A549 cells and Sprague-Dawley rats.
    Journal of applied toxicology : JAT, 2021, Volume: 41, Issue:3

    Topics: A549 Cells; Animals; Anti-Infective Agents, Local; Cell Survival; Cetylpyridinium; Disease Models, A

2021
Airway effects of inhaled quaternary ammonium compounds in mice.
    Basic & clinical pharmacology & toxicology, 2012, Volume: 110, Issue:6

    Topics: Aerosols; Animals; Benzalkonium Compounds; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cet

2012